Case report · 2018
Review articlePublished 16 Jan 2017
Chemotherapy for Patients with Renal Dysfunction
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Significant progress has been made in systemic chemotherapies for advanced cancer patients. Historically, the main anticancer drugs were cytotoxic agents, but recently, other agents such as molecularly-targeted therapies and immune checkpoint inhibitors have been introduced into clinical practice, and these agents have begun to achieve mainstream usage. The rapid development of novel anticancer drugs has forced clinicians to consider the effects of these chemotherapy agents in high-risk patients with liver or renal dysfunction, those undergoing dialysis and the elderly. Currently, there are no clear guidelines describing the best practices for anticancer drug administration in patients with renal dysfunction. However, the theory that renal dysfunction affects the ability of patients to cope with anticancer therapies is understandable compared with liver dysfunction or other risk factors. That is why there has always been an indication for dose adjustments for patients with renal dysfunction. In this review, recommended dose adjustments in cases of renal dysfunction are discussed based on the latest information on anticancer drugs.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 5 Oct 2017
Histological spectrum of neoadjuvant chemotherapy induced changes in childhood renal tumors as per SIOP protocol: A tertiary center experience
Conference abstract · 2 Nov 2015
Renal thrombotic micro-angiopathy associated with chemotherapy naive astrocytoma
Short communication · 31 Jul 2020
Renal dysfunction of therapy
Case report · 2019
Paraneoplastic Hepatic Dysfunction with Jaundice in a Case of Primary Renal Synovial Sarcoma: A very Rare Scenario
More from this journal
The newest in Journal of Clinical & Experimental Oncology.
Review article · 3 Jul 2025
Efficacy of interventions for newly diagnosed multiple myeloma: An umbrella review
Research article · 10 Apr 2025
Multitargets and Interactions of Wortmannin with MSC-Mitogenic Proteins Validate the Enhanced Antiproliferative Effect of MSCSecretome on Breast Cancer Michigan Cancer Foundation-7 Cells
Mini review · 24 Jan 2025
Fractal Analysis in Medical Images
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Koichi Suyama”
- BylineArticles whose byline prints “Yuji Miura”
- BylineArticles whose byline prints “Toshimi Takano”
- BylineArticles whose byline prints “Hirotaka Iwase”

